CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-16 | Topper James N Director | Other acquisition | +26,354 | 80,812 | ||
| 2020-07-30 | Lizzul Paul F. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2020-07-13 | LOUMEAU ERIC J COO, General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-07-13 | MULROY DENNIS Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +90,600 | 90,600 | ||
| 2020-03-10 | Suria Hamza President, CEO | Exercise or conversion | +10,000 | $1.12 | $11K | 47,636 |
| 2020-03-10 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 40,361 | ||
| 2020-02-12 | Ware J. Anthony Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2020-02-12 | Topper James N Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2020-02-12 | Schmid John P. Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2020-02-12 | RENTON HOLLINGS Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2020-02-12 | Hamill Laura Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2020-02-12 | FENTON DENNIS M Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2020-02-05 | Suria Hamza President, CEO | Exercise or conversion | +10,000 | $1.12 | $11K | 37,636 |
| 2020-02-05 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 50,361 | ||
| 2019-12-13 | Suria Hamza President, CEO | Grant or award · Employee Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2019-12-10 | Ware J. Anthony Director | Purchase | +3,600 | $14.05 | $51K | 3,600 |
| 2019-12-06 | LOUMEAU ERIC J General Counsel & Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +98,000 | 98,000 | ||
| 2019-12-06 | Londei Marco Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +98,000 | 98,000 | ||
| 2019-11-27 | Londei Marco Chief Medical Officer | Exercise or conversion | +46,202 | $6.93 | $320K | 68,579 |
| 2019-11-27 | Londei Marco Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −46,202 | 4,946 |
Page 26 of 27 · 522 trades